Bionor Pharma ASA issues share options to new CFO
Oslo 01.03.2013 - As part of the employment agreement Synne H Røine, newly appointed as ChiefFinancial Officer (CFO) at Bionor Pharma, has been granted 1 million shareoptions in Bionor Pharma.
The options are exercisable at a price of NOK 2.28 per share. The options vest
by 1/3 on 1 June 2014, 1/3 on 1 June 2015 and remaining 1/3 on 1 June 2016.
The share options can be issued according to the power of attorney from the
General Meeting on 11 May 2012 to issue up to 10 million options to
managementas part of the incentive system. The total number of outstanding
share options in Bionor Pharma is now 7.1 million.
Following the receipt of the options, Synne H Røine holds 0 shares and 1
million share options in Bionor Pharma.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.